Biontech Stock Analysis

BNTX -  USA Stock  

USD 404.92  9.52  2.30%

The current price rise of Biontech Se ADR could raise concerns from investors as the firm it trading at a share price of 404.92 on 7,263,318 in volume. The company executives may have good odds in positioning the firm resources to exploit market volatility in September. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.67. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Biontech partners.
Continue to Trending Equities.

Search Stock Analysis 

 
Refresh
The Biontech stock analysis report makes it easy to digest most publicly released information about Biontech and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Biontech Stock analysis module also helps to analyze the Biontech price relationship with some important fundamental indicators such as market cap and management efficiency.

Biontech Stock Analysis Notes

About 14.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.49. Biontech Se ADR had not issued any dividends in recent years. BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany. Biontech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2200 people. For more info on Biontech Se ADR please contact the company at 49 6131 9084 0 or go to http://www.biontech.de.

Biontech Se ADR Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Biontech's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Biontech Se ADR or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Biontech Se ADR appears to be risky and price may revert if volatility continues
Biontech Se ADR currently holds about 892 M in cash with (270.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.69.
Biontech Se ADR has a poor financial position based on the latest SEC disclosures
Latest headline from investmentu.com: Stocks That Are About To Blow Up - Investment U

Biontech Se ADR Upcoming and Recent Events

Earnings reports are used by Biontech to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Biontech previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report9th of August 2021
Next Earnings Report9th of November 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End29th of March 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

Biontech SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Biontech prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Biontech investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Biontech Se ADR specific information freely available to individual and institutional investors to make a timely investment decision.

Biontech Market Capitalization

The company currently falls under 'Mega-Cap' category with current market capitalization of 100.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biontech's market, we take the total number of its shares issued and multiply it by Biontech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Biontech Profitablity

Biontech's profitability indicators refer to fundamental financial ratios that showcase Biontech's ability to generate income relative to its revenue or operating costs. If, let's say, Biontech is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Biontech's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Biontech's profitability requires more research than a typical breakdown of Biontech's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 47.81 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 51.42 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.51.
Last ReportedProjected for 2021
Return on Average Assets 0.01  0.0108 
Return on Average Equity 0.016  0.0164 
Return on Invested Capital(0.20) (0.21) 
Return on Sales(0.17) (0.18) 

Management Efficiency

The entity has return on total asset (ROA) of 32.59 % which means that it generated profit of $32.59 on every $100 spent on asset. This is very large. Similarly, it shows return on stockholders equity (ROE) of 80.65 %, meaning that it created $80.65 on every $100 dollars invested by stockholders. Biontech management efficiency ratios could be used to measure how well biontech se adr manages its routine affairs as well as how well it operates its assets and liabilities. Biontech Return on Average Assets are fairly stable at the moment as compared to the past year. Biontech reported Return on Average Assets of 0.01 in 2020. Return on Average Equity is likely to rise to 0.0164 in 2021, whereas Return on Invested Capital is likely to drop (0.21)  in 2021. Biontech Total Assets are fairly stable at the moment as compared to the past year. Biontech reported Total Assets of 2.32 Billion in 2020. Current Assets is likely to rise to about 1.8 B in 2021, whereas Assets Non Current are likely to drop slightly above 528 M in 2021.
Last ReportedProjected for 2021
Book Value per Share 6.05  5.00 
Enterprise Value over EBIT(182.00) (186.79) 
Enterprise Value over EBITDA(350.01) (359.22) 
Price to Book Value 11.05  11.05 
Tangible Assets Book Value per Share 9.50  7.92 
Enterprise Value18 B16.8 B
Tangible Asset Value2.2 B2.3 B

Technical Drivers

As of the 5th of August, Biontech shows the Risk Adjusted Performance of 0.1786, downside deviation of 4.37, and Mean Deviation of 3.8. Biontech Se ADR technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Biontech Se ADR, which can be compared to its rivals. Please confirm Biontech Se ADR coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if Biontech Se ADR is priced correctly, providing market reflects its regular price of 404.92 per share. Given that Biontech has jensen alpha of 1.15, we suggest you to validate Biontech Se ADR's prevailing market performance to make sure the company can sustain itself at a future point.

Biontech Se ADR Price Movement Analysis

The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Biontech middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Biontech Se ADR. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

Biontech Predictive Daily Indicators

Biontech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biontech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Biontech Forecast Models

Biontech time-series forecasting models is one of many Biontech's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biontech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Biontech Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Biontech stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biontech shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Biontech. By using and applying Biontech Stock analysis, traders can create a robust methodology for identifying Biontech entry and exit points for their positions.
Last ReportedProjected for 2021
EBITDA Margin(0.09) (0.09) 
Gross Margin 0.88  0.96 
Profit Margin 0.032  0.0345 
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany. Biontech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2200 people.

Current Biontech Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Biontech analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Biontech analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
175.0Hold8Odds
Biontech Se ADR current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Biontech analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Biontech stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Biontech Se ADR, talking to its executives and customers, or listening to Biontech conference calls.
Biontech Analyst Advice Details

Biontech Stock Analysis Indicators

Biontech Se ADR stock analysis indicators help investors evaluate how Biontech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Biontech shares will generate the highest return on investment. By understating and applying Biontech stock analysis, traders can identify Biontech position entry and exit signals to maximize returns.
Quick Ratio2.51
Fifty Two Week Low54.10
Revenue Growth7,294.90%
Shares Short Prior Month3.83M
Average Daily Volume Last 10 Day4.36M
Average Daily Volume In Three Month3.27M
Shares Percent Shares Out1.28%
Gross Margins56.75%
Forward Price Earnings13.76
Float Shares78.56M
Fifty Two Week High433.90
Enterprise Value To Ebitda42.66
Fifty Day Average245.34
Two Hundred Day Average169.96
Enterprise Value To Revenue22.57
Continue to Trending Equities. Note that the Biontech Se ADR information on this page should be used as a complementary analysis to other Biontech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Transformation module to use Price Transformation models to analyze depth of different equity instruments across global markets.

Complementary Tools for Biontech Stock analysis

When running Biontech Se ADR price analysis, check to measure Biontech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biontech is operating at the current time. Most of Biontech's value examination focuses on studying past and present price action to predict the probability of Biontech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Biontech's price. Additionally, you may evaluate how the addition of Biontech to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
The market value of Biontech Se ADR is measured differently than its book value, which is the value of Biontech that is recorded on the company's balance sheet. Investors also form their own opinion of Biontech's value that differs from its market value or its book value, called intrinsic value, which is Biontech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biontech's market value can be influenced by many factors that don't directly affect Biontech Se ADR underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biontech's value and its price as these two are different measures arrived at by different means. Investors typically determine Biontech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biontech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.